USP18 and type 2 diabetes mellitus: USP18 is also downregulated in a mouse model of T2DM [111], and in transgenic mice, obesity-induced insulin resistance was ameliorated and aggravated by hepatocyte-selective Usp18 overexpression and deficiency, respectively [111].